Thoraxklinik

Heidelberg 69126

1 studies enrolling now · 7 studies all time

What they study most

Cancer, Connective Tissue Disease-Associated Pulmonary Arterial Hypertension, Idiopathic Pulmonary Fibrosis, Lung Cancer, Pulmonary Hypertension, Squamous Cell Carcinoma, Non-Small-Cell Lung

Studies at this site

• Pan Tumor Rollover Study — Recruiting now
• Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER — Stopped early
• Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST — Stopped early
• A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care — Stopped early
• Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer — Completed
• Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2 — Completed
• ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis — Stopped early